Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?

No standard treatment has been established for metastatic uveal melanoma (mUM). Immunotherapy is commonly used for this disease even though UM has not been included in phase III clinical trials with checkpoint inhibitors. Unfortunately, only a minority of patients obtain a clinical benefit with immu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Rossi, Ernesto, Schinzari, Giovanni, Zizzari, Ilaria Grazia, Maiorano, Brigida Anna, Pagliara, Monica Maria, Sammarco, Maria Grazia, Fiorentino, Vincenzo, Petrone, Gianluigi, Cassano, Alessandra, Rindi, Guido, Bria, Emilio, Blasi, Maria Antonietta, Nuti, Marianna, Tortora, Giampaolo
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721347/
https://ncbi.nlm.nih.gov/pubmed/31357439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081055
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki